Skip to main content
Log in

Akanthamöbenkeratitis

Acanthamoeba keratitis

  • CME Zertifizierte Fortbildung
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Das typische Bild der Akanthamöbenkeratitis zeichnet sich durch pseudodendritiforme Epitheliopathie, Perineuritis, Ringinfiltrat oder multifokale stromale Infiltrate aus. Jedoch können auch eine Limbitis mit Infiltration der Konjunktiva oder eine Uveitis anterior auftreten. Etwa 83–93 % der Patienten mit Akanthamöbenkeratitis sind Kontaktlinsenträger. Die Diagnosestellung einer Akanthamöbeninfektion erfolgt anhand von Polymerasekettenreaktion (PCR), konfokaler Biomikroskopie, In-vitro-Kultivierung oder histopathologischen Untersuchungen. Bisher liegen keine randomisierten kontrollierten klinischen Studien vor, daher stammen die Informationen über Effektivität und Sicherheit der medikamentösen und chirurgischen Therapie nur aus publizierten Fallserien. Es wird eine 3-fache medikamentöse Therapie aus Polyhexamid, Propamidinisoethionat und Neomycin zur Behandlung empfohlen, die bis zu einem Jahr angewendet werden sollte. Bei Therapieresistenz kann eine Kryotherapie, Amnionmembrantransplantation, Crosslinkingtherapie oder eine therapeutische Keratoplastik notwendig werden. Bestanden 3 Monate lang vor einer geplanten Keratoplastik keine Infektionszeichen mehr, ist die Prognose am besten.

Abstract

The typical clinical appearance of acanthamoeba keratitis includes pseudodendritic epitheliopathy, perineuritis, ring infiltrates or multifocal stromal infiltrates and in some cases limbitis with infiltration of the conjunctiva and/or sterile anterior uveitis. In 83–93 % of cases of acanthamoeba keratitis the patients were contact lens wearers. Acanthamoeba keratitis is diagnosed by polymerase chain reaction (PCR), confocal biomicroscopy, in vitro cultivation and histopathological examination. Information on reliability and efficacy of conservative and surgical therapy of acanthamoeba keratitis has only been published in case series but not yet verified through randomized controlled clinical studies. After early diagnosis acanthamoeba keratitis can often be successfully treated using triple topical therapy with polyhexamide, propamidine isethionate and neomycin. Topical therapy should be continued for up to 1 year. In therapy-resistant cases cryotherapy, amniotic membrane transplantation, crosslinking therapy and therapeutic keratoplasty can be performed. The prognosis of keratoplasty following acanthamoeba keratitis is more favorable if there were no signs of infection at least 3 months before surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Meltendorf C, Duncker G (2011) Akanthamöben-Keratitis. Klin Monatsbl Augenheilkd 228:R29–R43

    Article  CAS  PubMed  Google Scholar 

  2. Szentmáry N, Göbels S, Matoula P et al (2012) Die Akanthamöbenkeratitis – ein seltenes und oft spät diagnostiziertes Chamäleon. Klin Monatsbl Augenheilkd 229:521–528

    Article  PubMed  Google Scholar 

  3. Panjwani N (2010) Pathogenesis of Acanthamoeba keratitis. Ocul Surf 8:70–79

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hadas E, Mazur T (1993) Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp. Trop Med Parasitol 44:197–200

    CAS  PubMed  Google Scholar 

  5. Moore MB, McCulley JP, Kaufman HE, Robin JB (1986) Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. Ophthalmology 93:1310–1315

    Article  CAS  PubMed  Google Scholar 

  6. Weekers PH, Bodelier PL, Wijen JP et al (1993) Effects of grazing by the free-living soil amoebae Acanthamoeba castellanii, Acanthamoeba polyphaga, and Hartmannella vermiformis on various bacteria. Appl Environ Microbiol 59:2317–2319

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Gupta S, Das SR (1999) Stock cultures of free-living amebas: effect of temperature on viability and pathogenicity. J Parasitol 85:137–139

    Article  CAS  PubMed  Google Scholar 

  8. Aksozek A, McClellan K, Howard K et al (2002) Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol 88:621–623

    CAS  PubMed  Google Scholar 

  9. Mazur T, Hadas E, Iwanicka I (1995) The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop Med Parasitol 46:106–108

    CAS  PubMed  Google Scholar 

  10. Pussard M, Pons R (1977) Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica 13:557–610

    Google Scholar 

  11. Stothard DR, Hay J, Schroeder-Diedrich JM et al (1999) Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type. J Clin Microbiol 37:2687–2693

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Naginton J, Watson PG, Playfair TJ et al (1974) Amoebic infection of the eye. Lancet 2:1537–1540

    Article  CAS  PubMed  Google Scholar 

  13. Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3–10

    Article  CAS  PubMed  Google Scholar 

  14. Seal DV (2003) Acanthamoeba keratitis update – incidence, molecular epidemiology and new drugs for treatment. Eye (Lond) 17:893–905

    Google Scholar 

  15. Acharya NR, Lietman TM, Margolis TP (2007) Parasites on the rise: a new epidemic of Acanthamoeba keratitis. Am J Ophthalmol 144:292–293

    Article  PubMed  Google Scholar 

  16. Carvalho FR, Foronda AS, Mannis MJ et al (2009) Twenty years of Acanthamoeba keratitis. Cornea 28:516–519

    Article  CAS  PubMed  Google Scholar 

  17. Radford CF, Lehmann OJ, Dart JK (1998) National Acanthamoeba Keratitis Study Group. Acanthamoeba keratitis: multicentre survey in England 1992–6. Br J Ophthalmol 82:1387–1392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Watt K, Swarbrick HA (2005) Microbial keratitis in overnight orthokeratology: review of the first 50 cases. Eye Contact Lens 31:201–208

    Article  PubMed  Google Scholar 

  19. Hammersmith KM (2006) Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 17:327–331

    Article  PubMed  Google Scholar 

  20. Johnston SP, Sriram R, Qvarnstrom Y et al (2009) Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. J Clin Microbiol 47:2040–2045

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sharma S, Garg P, Rao GN (2000) Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84:1103–1108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Dart JK, Saw VP, Kilvington S (2009) Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 148:487–499

    Article  PubMed  Google Scholar 

  23. Reinhard T, Behrens-Baumann W (2006) Anti-infective drug therapy in ophthalmology – part 4: Acanthamoeba keratitis. Klin Monatsbl Augenheilkd 223:485–492

    Article  CAS  PubMed  Google Scholar 

  24. Pfister DR, Cameron JD, Krachmer JH et al (1996) Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol 121:119–128

    CAS  PubMed  Google Scholar 

  25. Mathers WD, Sutphin JE, Folberg R et al (1996) Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 121:129–142

    CAS  PubMed  Google Scholar 

  26. Aspöck H (2006) Grundzüge der Diagnostik. In: Hiepe T, Lucius R, Gottstein B (Hrsg) Allgemeine Parasitologie mit den Grundzügen der Immunologie, Diagnostik und Bekämpfung. Parey in MVS Medizinverlage, Stuttgart, S 477

  27. Sharma S, Athmanathan S, Atha-Ur-Rasheed M et al (2001) Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. Indian J Ophthalmol 49:181–186

    CAS  PubMed  Google Scholar 

  28. Claerhout I, Goegebuer A, Van Den Broecke C et al (2004) Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol 242:648–653

    Article  CAS  PubMed  Google Scholar 

  29. Awwad ST, Petroll WM, McCulley JP et al (2007) Updates in Acanthamoeba keratitis. Eye Contact Lens 33:1–8

    Article  PubMed  Google Scholar 

  30. Perry HD, Donnenfeld ED, Foulks GN et al (1995) Decreased corneal sensation as an initial feature of Acanthamoeba keratitis. Ophthalmology 102:1565–1568

    Article  CAS  PubMed  Google Scholar 

  31. Papathanassiou M, Gartry D (2007) Steril corneal ulcer with ring infiltrate and hypopyon after recurrent erosions. Eye 21:124–126

    Article  CAS  PubMed  Google Scholar 

  32. Patel DV, McGhee CN (2009) Acanthamoeba keratitis: a comprehensive photographic reference of common and uncommon signs. Clin Experiment Ophthalmol 37:232–238

    Article  PubMed  Google Scholar 

  33. Kremer I, Cohen EJ, Eagle RC Jr et al (1994) Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 20:45–48

    CAS  PubMed  Google Scholar 

  34. Clarke DW, Alizadeh H, Niederkorn JY (2005) Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci 46:2472–2478

    Article  PubMed  Google Scholar 

  35. Herz NL, Matoba AY, Wilhelmus KR (2008) Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology 115:866–869

    Article  PubMed  Google Scholar 

  36. Kelley PS, Dossey AP, Patel D et al (2006) Secondary glaucoma associated with advanced acanthamoeba keratitis. Eye Contact Lens 32:178–182

    Article  PubMed  Google Scholar 

  37. Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99:185–191

    Article  CAS  PubMed  Google Scholar 

  38. Ficker L, Seal D, Warhurst D et al (1990) Acanthamoeba keratitis – resistance to medical therapy. Eye (Lond) 4(Pt 6):835–838

    Google Scholar 

  39. Wright P, Warhurst D, Jones BR (1985) Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 69:778–782

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Elder MJ, Kilvington S, Dart JK (1994) A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 35:1059–1064

    CAS  PubMed  Google Scholar 

  41. McClellan K, Howard K, Niederkorn JY et al (2001) Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 42:2885–2893

    CAS  PubMed  Google Scholar 

  42. D’Aversa G, Stern GA, Driebe WT Jr (1995) Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 113:1120–1123

    Article  Google Scholar 

  43. Amoils SP, Heney C (1999) Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am J Ophthalmol 127:718–720

    Article  CAS  PubMed  Google Scholar 

  44. Oldenburg CE, Acharya NR, Tu EZ et al (2011) Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea 30:1363–1368

    Article  PubMed  PubMed Central  Google Scholar 

  45. Brooks JG Jr, Coster DJ, Badenoch PR (1994) Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea 13:186–189

    Article  PubMed  Google Scholar 

  46. Szentmáry N, Goebels S, Bischoff M, Seitz B (2012) Photodynamische Therapie (PDT) bei infektiöser Keratitis. Ophthalmologe 109:165–170

    Article  PubMed  Google Scholar 

  47. Khan YA, Kashiwabuchi RT, Martins SA et al (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeben keratitis: report of 3 cases. Ophthalmology 118:324–331

    Article  PubMed  Google Scholar 

  48. Kitzmann AS, Goins KM, Sutphin JE et al (2009) Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 116:864–869

    Article  PubMed  Google Scholar 

  49. Seitz B, Langenbucher A, Kuss MM et al (1999) Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty. Ophthalmology 106(6):1556–1564

    Google Scholar 

  50. Szentmáry N, Langenbucher A, Kus MM et al (2007) Elliptical nonmechanical corneal trephination – Intraoperative complications and long-term outcome of 42 consecutive penetrating keratoplasties. Cornea 26:414–420

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. N. Szentmáry, L. Daas, P. Matoula, S. Goebels und B. Seitz geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Szentmáry.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szentmáry, N., Daas, L., Matoula, P. et al. Akanthamöbenkeratitis. Ophthalmologe 110, 1203–1211 (2013). https://doi.org/10.1007/s00347-013-2981-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-013-2981-0

Schlüsselwörter

Keywords

Navigation